Wells Fargo & Company Entasis Therapeutics Holdings Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$1.75 - $2.2 $855 - $1,075	-489 Reduced 30.3%	1,125 $2,000
Q4 2021 Feb 14, 2022	BUY	$2.1 - $3.4 $2 - $3	1 Added 0.06%	1,614 $3,000
Q3 2021 Nov 15, 2021	BUY	$2.27 - $3.77 $88 - $147	39 Added 2.48%	1,613 $5,000
Q2 2021 Aug 16, 2021	SELL	$1.82 - $3.04 $3,634 - $6,070	-1,997 Reduced 55.92%	1,574 $4,000
Q1 2021 May 13, 2021	BUY	$2.01 - $3.53 $4 - $7	2 Added 0.06%	3,571 $7,000
Q4 2020 Feb 09, 2021	SELL	$1.61 - $2.85 $3,220 - $5,700	-2,000 Reduced 35.91%	3,569 $9,000
Q3 2020 Nov 05, 2020	BUY	$2.04 - $4.03 $108 - $213	53 Added 0.96%	5,569 $11,000
Q2 2020 Aug 13, 2020	SELL	$2.31 - $3.32 $5,775 - $8,300	-2,500 Reduced 31.19%	5,516 $16,000
Q1 2020 May 14, 2020	BUY	$1.99 - $5.56 $15,951 - $44,568	8,016 New	8,016 $21,000

About Entasis Therapeutics Holdings Inc.

Ticker ETTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,851,800
Market Cap $105M

More about ETTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.